Efficacy, durability, and safety of faricimab with extended dosing up to every 16 weeks in Japanese patients with diabetic macular edema: 1-year results from the Japan subgroup of the phase 3 YOSEMITE trial
Japanese journal of ophthalmology, 2023-05, Vol.67 (3), p.264 [Peer Reviewed Journal]2023. Japanese Ophthalmological Society. ;EISSN: 1613-2246 ;DOI: 10.1007/s10384-023-00979-8 ;PMID: 36897413
Digital Resources/Online E-Resources